2022 Summit on Cancer Health Disparities

Seattle, WA US
April 29, 2022 to May 1, 2022

Learning Objectives

At the conclusion of the activity, participants will be able to:

  1. Identify drivers of cancer health disparities and review their impact on patients along the cancer continuum.
  2. State the financial and physical barriers, review strategies to navigate these factors to optimize management of patients with cancer.
  3. Incorporate evidence-based strategies to minimize the impact of specific drivers of inequity in the management of patients with cancer.
  4. Describe challenges and develop novel approaches to improve participation of underrepresented communities in clinical trials.

ABSTRACT SUBMISSION INFORMATION

ABSTRACT SUBMISSION DEADLINE: January 10, 2022 11:59 PM Pacific Time

 

We will accept abstracts in the following categories. 

Please select a category that fits the submission best when submitting the abstract.

  • Technology
  • Tumor biology
  • Precision oncology
  • Epidemiology
  • Screening
  • Health policy
  • Survivorship
  • Quality improvement
  • Database analysis
  • Encore abstracts: The abstract committee will accept encore clinical trials abstracts for this conference. Submissions with additional data that supplement the previous presentation will be preferred. Authors should provide information regarding the original presentation, including the name of the meeting where the abstract was originally presented.

Course summary
Available credit: 
  • 14.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 14.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 14.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 14.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 14.00 Contact Hours.
Course opens: 
09/21/2021
Course expires: 
06/01/2022
Event starts: 
04/29/2022 - 7:52am
Event ends: 
05/01/2022 - 5:00pm
Cost:
$450.00

Conference Chairs: David Aboulafia, MD, Edith P. Mitchell, MD, and Hannah Linden, MD, FACP

All times listed below are in Pacific Standard Time.

April 29, 2022

3:00 PM – 3:15 PM PST: Welcome


Session 1: 3:15 PM – 4:15 PM PST: Access to insurance and cancer disparities

3:15 - 3:30 PM PST: Access to insurance and access to cancer care – 

3:30 - 3:45 PM PST: ACA and access to cancer care

3:45 - 4:00 PM PST: Experience from a county hospital 

4:00 - 4:15 PM PST: Panel discussion / Q&A


Session 2: 4:15 PM – 5:15 PM PST: Cancer care disparities – training the next generation

4:15 - 4:25 PM PST: Career in cancer care disparities 

4:25 - 4:35 PM PST: Funding opportunities for disparities research 

4:35 - 5:15 PM PST: Panel discussion


5:15 PM to 6:30 PM PST: Abstract session


April 30, 2022

Session 1: 08:00 AM to 09:45 AM PST: Technology and cancer disparities

8:00 - 8:15 AM PST: Telemedicine for cancer care after the COVID-19 pandemic: lessons learned 

8:15 - 8:30 AM PST: Mitigating disparities potentially magnified by telemedicine: Addressing "Techquity" 

8:30 - 8:45 AM PST: Project ECHO and delivering global oncology

8:45 - 9:00 AM PST: Panel discussion, Q/A on telemedicine addressing or worsening disparities

9:00 - 9:15 AM PST: Asynchronous integration of an oncology subspecialist with local delivery of cancer care: The AccessHope experience 

9:15 - 9:30 AM PST: Virtual tumor boards to bring subspecialist care beyond tertiary care centers 

9:30 - 9:45 AM PST: Panel discussion, Q/A on models for overcoming geographic barriers to increasingly complex oncology delivery


9:45 - 10:15 AM PST: Break 


Session 2: 10:15 AM to 12:00 PM PST: Breast Cancer Disparities Session – sponsored by BCRF

10:15 - 10:30 AM PST: Lancet Commission on Women and Cancer

10:30 - 10:45 AM PST: WHO Global Breast Cancer Initiative  

10:45 - 11:00 AM PST: Overcoming Racial, Ethnic, and Socioeconomic Disparities in Breast Cancer Care in the US 

11:00 - 11:15 AM PST: University of Washington Equity Initiative 

11:15 - 12:00 PM PST: Panel Discussion


12:00 - 01:00 PM PST: Lunch


Session 3: 1:00 PM to 2:15 PM PST: Professional Societies’ initiatives in improving cancer health disparities

1:00 - 1:30 PM PST: Society President or representative presentations

1:30 - 2:15 PM PST: Panel discussion


2:15 PM to 2:45 PM PST: Break


Session 4: 2:45 PM to 4:15 PM PST: Cancer Health Disparities in the LGBTQ population

2:45 - 3:00 PM PST: Anal cancer screening 

3:00 - 3:15 PM PST: Cultural barriers to equity and cancer disparities among sexual and gender minorities 

3:15 - 3:30 PM PST: Cancer screening among HIV-infected women 

3:30 - 3:45 PM PST: Partnering with patients to accelerate cancer research 

3:45 - 4:15 PM PST: Panel discussion


6:00 - 9:00 PM PST: Gala dinner


May 01, 2022

Session 1: 8:00 AM to 9:15 AM PST: Global Oncology 

8:00 - 8:15 AM PST: The promise of Universal Health Coverage (UHC) for global cancer: moving from challenges to solutions

8:15 - 8:30 AM PST: Levelling the field in cancer research to control global cancer burden

8:30 - 8:45 AM PST: Understanding of anthropology for cancer control to tackle disparities in cancer care

8:45 - 9:15 AM PST: Panel discussion


9:15 - 9:45 AM  PST: Break 


Session 2: 9:45 - 11:00 AM PST: Clinical Trials and Disparities in cancer care

9:45 - 10:00 AM PST: Keynote speech 

10:00 - 11:00 AM PST: Panel discussion 


Session 3: 11:05 AM to 12:05 PM PST: Precision oncology/cellular therapies and cancer disparities

11:05 - 11:20 AM PST: Challenges of precision oncology in developing nations

11:20 - 11:35 AM PST: Promises and pitfalls of tissue agnostic drug development

11:35 - 12:05 PM PST: Debate – Precision medicine is a mirage and leads to disparities in care versus precision medicine is the reality and future of oncology and is for all


12:05 - 01:00 PM PST: Lunch


Session 4: 1:00 - 2:00 PM PST: Plenary lectures


2:00 - 2:15 PM PST: Break


Session 5: 2:15 - 3:30 PM PST: Debates


3:35 PM PST: Adjourn

 

Grand Hyatt Seattle
721 Pine St
Seattle, WA 98101
United States

 

Speaker(s)

GHASSAN ABOU-ALFA, MD

has no relevant financial relationships to disclose at this time.

David Aboulafia, MD

has no relevant financial relationships to disclose at this time.

Chandrikha Chandrasekharan, MBBS

has no relevant financial relationships to disclose at this time.

Chadi Nabhan, MD MBA

has no relevant financial relationships to disclose at this time.

Aparna Parikh, MD

has a financial relationship (Other) with Eli Lilly ;.
has a financial relationship (Other) with Roche;.
has a financial relationship (Other) with Pfizer ;.
has a financial relationship (Other) with C2i genomics;.

Rachna Shroff, MD

has no relevant financial relationships to disclose at this time.

Bhawna Sirohi, MBBS, FRCP

has no relevant financial relationships to disclose at this time.

Dingle Spence, MBBS, Dip Pall Med, FRCR

has no relevant financial relationships to disclose at this time.

Howard (Jack) West, MD, Associate Professor, City of Hope Cancer Center, Los Angeles, CA

has a financial relationship (Independent contractor) with Genentech/Roche;.
has a financial relationship (Independent contractor) with Takeda;.
has a financial relationship (Independent contractor) with Regeneron;.
has a financial relationship (Independent contractor) with AstraZeneca;.
has a financial relationship (Independent contractor) with Mirati;.
has a financial relationship (Independent contractor) with Merck;.

Siddhartha Yadav, Siddhartha Yadav, MD, FACP

has no relevant financial relationships to disclose at this time.

Available Credit

  • 14.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 14.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 14.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 14.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 14.00 Contact Hours.

If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information

Price

Cost:
$450.00
Please login or register to take this course.

Cancellation Policy

Refund Policy